Citation Impact
Citing Papers
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review.
2012
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
The use of ketamine as an antidepressant: a systematic review and meta‐analysis
2015
A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder
2011
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
2014
Depression
2018 Standout
Cognitive impairment in euthymic major depressive disorder: a meta-analysis
2012
The Relationship Between Neurocognitive and Psychosocial Functioning in Major Depressive Disorder
2014
Major depressive disorder
2016 Standout
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Does the Blood-brain Barrier Play a Role in Glaucoma?
2007
The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial
2019
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
2018
Frontal Theta Cordance Predicts 6-Month Antidepressant Response to Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression: A Pilot Study
2012
Nitrosative stress and pharmacological modulation of heart failure
2005
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
2018
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Structure and function of the blood–brain barrier
2009 Standout
Ketamine and other potential glutamate antidepressants
2014
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
2019 Standout
Psychedelics
2016 Standout
Cardioprotective effects of poly(ADP-ribose) polymerase inhibition
2005
Prevalencia de desgaste profesional y psicomorbilidad en médicos de atención primaria de un área sanitaria de Madrid
2003
Wake and sleep EEG provide biomarkers in depression
2009
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Clinical applications of hallucinogens: A review.
2016
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Síndrome de desgaste profesional en los médicos de atención primaria de Ávila
2014
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Burnout in the intensive care unit professionals
2016 Standout
Ketamine administration in depressive disorders: a systematic review and meta-analysis
2014
A New, Potent Poly(ADP-ribose) Polymerase Inhibitor Improves Cardiac and Vascular Dysfunction Associated with Advanced Aging
2004
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
Regulated necrosis: disease relevance and therapeutic opportunities
2016
The neural basis of psychedelic action
2022 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
2008
AKT/PKB Signaling: Navigating the Network
2017 Standout
ROS Are Good
2016 Standout
<p>Ketamine and depression: a narrative review</p>
2019
Role of Poly(ADP‐ribose) polymerase 1 (PARP‐1) in Cardiovascular Diseases: The Therapeutic Potential of PARP Inhibitors
2007
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
2011
The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction
2006
Psychedelics and Other Psychoplastogens for Treating Mental Illness
2021
Estudio sobre la prevalencia del burnout en los médicos del Área Sanitaria de Talavera de la Reina
2003
The neurobiology of depression and antidepressant action
2012
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
2016
Síndrome de burnout en los ginecólogos del Hospital Universitario Virgen Macarena de Sevilla
2008
PTEN Activity Is Modulated During Ischemia and Reperfusion
2005 StandoutNobel
Association of occupational burnout and type of personality in Iranian general practitioners
2015
Prevalence of Burnout Among Physicians
2018 Standout
Large-Scale Network Dysfunction in Major Depressive Disorder
2015 Standout
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
2015
On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
2017 Standout
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
2012 Standout
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Pharmacological Activation of Soluble Guanylate Cyclase Protects the Heart Against Ischemic Injury
2009
Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure
2006
A review of depression and suicide risk assessment using speech analysis
2015 Standout
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
2020
Prevalencia de desgaste profesional y psicomorbilidad en médicos de atención primaria de un área sanitaria de Madrid
2003
Works of P. Šóš being referenced
Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
2013
Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder
2008
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
2017
The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments
2010
Rasgos de personalidad y burnout en médicos de familia
2001
Cognitive deficits in the euthymic phase of unipolar depression
2009
INO-1001 A NOVEL POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR IMPROVES CARDIAC AND PULMONARY FUNCTION AFTER CRYSTALLOID CARDIOPLEGIA AND EXTRACORPORAL CIRCULATION
2004
Changes of Endothelin-1 and Big Endothelin-1 Levels and Action Potential Duration during Myocardial Ischemia-reperfusion in Dogs with and without Ventricular Fibrillation
2004